FDA clears first AI tool for breast cancer risk prediction from startup Clairity
Startup Clairity scored a greenlight from the FDA for the agency's first artificial intelligence tool designed to predict five-year breast cancer risk from a routine screening mammogram.
Startup Clairity scored a greenlight from the FDA for the agency's first artificial intelligence tool designed to predict five-year breast cancer risk from a routine screening mammogram.
